<?xml version='1.0' encoding='ISO-8859-1' ?>
<rss version="2.0">
	<channel>
		<title>TrialResults-center - acute coronary syndrome - Trials recently added</title>
		<link>http://www.trialresultscenter.org/</link>
		<description><![CDATA[TrialResults-center is a knowledge base allowing easy access to the clinical trials results]]></description>
		<language>fr</language>
		<copyright>Copyright 2004-2009 TrialResults-center team</copyright>
		<pubDate>04/09/2010 01:40:30</pubDate>
		<lastBuildDate>04/09/2010 01:40:30</lastBuildDate>
				
			<item>
				<title><![CDATA[J-LANCELOT -  atopaxar  vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					atopaxar at a loading dose of 400 mg followed by  50 mg per day, 100 mg per day, or 200 mg per day for 12 weeks <i>versus</i> atopaxar at a loading dose of 400 mg followed by placebo
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>31/08/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[J-LANCELOT -  atopaxar  vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					atopaxar at a loading dose of 400 mg followed by  50 mg per day, 100 mg per day, or 200 mg per day for 12 weeks <i>versus</i> atopaxar at a loading dose of 400 mg followed by placebo
					added in section
					acute coronary syndrome - antiplatelets drug - ACS (excluding AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m169.htm]]></link>	
				<pubDate>31/08/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[J-LANCELOT -  atopaxar  vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					atopaxar at a loading dose of 400 mg followed by  50 mg per day, 100 mg per day, or 200 mg per day for 12 weeks <i>versus</i> atopaxar at a loading dose of 400 mg followed by placebo
					added in section
					acute coronary syndrome - antiplatelets drug - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m346.htm]]></link>	
				<pubDate>31/08/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[AMIHOT II  -  supersaturated oxygen vs control]]></title> 
				<description><![CDATA[New trials comparing
					90-minute intracoronary supersaturated oxygen  (SSO(2)) infusion in the left anterior descending artery infarct territory <i>versus</i> control
					added in section
					acute coronary syndrome - oxygen therapy - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m428.htm]]></link>	
				<pubDate>16/06/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[AMIHOT II  -  supersaturated oxygen vs control]]></title> 
				<description><![CDATA[New trials comparing
					90-minute intracoronary supersaturated oxygen  (SSO(2)) infusion in the left anterior descending artery infarct territory <i>versus</i> control
					added in section
					acute myocardial infarction - oxygen therapy - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m429.htm]]></link>	
				<pubDate>16/06/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[AMIHOT -  supersaturated oxygen vs control]]></title> 
				<description><![CDATA[New trials comparing
					hyperoxemic reperfusion  for 90 min using intracoronary  aqueous oxygen <i>versus</i> normoxemic blood autoreperfusion
					added in section
					acute coronary syndrome - oxygen therapy - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m428.htm]]></link>	
				<pubDate>16/06/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[AMIHOT -  supersaturated oxygen vs control]]></title> 
				<description><![CDATA[New trials comparing
					hyperoxemic reperfusion  for 90 min using intracoronary  aqueous oxygen <i>versus</i> normoxemic blood autoreperfusion
					added in section
					acute myocardial infarction - oxygen therapy - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m429.htm]]></link>	
				<pubDate>16/06/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[ACAPULCO -  prasugrel vs clopidogrel]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>05/04/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[ACAPULCO -  prasugrel vs clopidogrel]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antiplatelets drug - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m346.htm]]></link>	
				<pubDate>05/04/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - anticoagulant - All ACS (including AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m167.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - direct factor Xa inhibitors - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m345.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - patients with a recent ACS 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m387.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - anticoagulant - All ACS (including AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m167.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - direct factor Xa inhibitors - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m345.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - patients with a recent ACS 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m387.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[PLATO -  ticagrelor + aspirin vs clopidogrel + aspirin]]></title> 
				<description><![CDATA[New trials comparing
					ticagrelor 90mg twice daily <i>versus</i> clopidogrel 75mg once daily
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>30/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[PLATO -  ticagrelor + aspirin vs clopidogrel + aspirin]]></title> 
				<description><![CDATA[New trials comparing
					ticagrelor 90mg twice daily <i>versus</i> clopidogrel 75mg once daily
					added in section
					acute coronary syndrome - antiplatelets drug - ACS (excluding AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m169.htm]]></link>	
				<pubDate>30/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[PLATO -  ticagrelor + aspirin vs clopidogrel + aspirin]]></title> 
				<description><![CDATA[New trials comparing
					ticagrelor 90mg twice daily <i>versus</i> clopidogrel 75mg once daily
					added in section
					acute coronary syndrome - antiplatelets drug - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m346.htm]]></link>	
				<pubDate>30/08/2009</pubDate>
			</item>
			
	</channel>
</rss>
